awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41610309-BA22D592-C200-47D0-B6E4-A2063D76EEA7
Q41610309-BA22D592-C200-47D0-B6E4-A2063D76EEA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41610309-BA22D592-C200-47D0-B6E4-A2063D76EEA7
Single dose methodology to assess the influence of an alpha1-adrenoceptor antagonist on uroflowmetric parameters in patients with benign prostatic hyperplasia.
P2860
Q41610309-BA22D592-C200-47D0-B6E4-A2063D76EEA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41610309-BA22D592-C200-47D0-B6E4-A2063D76EEA7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e1beb32710c5bac3e194591480d430d674d9b82c
P2860
Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study.